Phase I/II Trial rHuKFG for the Treatment of Steroid Refractory Gastrointestinal Acute GVHD

Phase 1/2 Terminated 7 enrolled M.D. Anderson Cancer Center Amgen · collab

Non-randomizedSingle-groupOpen-labelTreatment

Summary

Phase II efficacy evaluation, phase I/II efficacy and toxicity trial of recombinant human keratinocyte growth factor for the treatment of steroid refractory gastrointestinal graft versus host disease.

Timeline

Start: 2000-10
Primary completion: 2003-01
Completion: 2003-01

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Palifermin	Protein / enzyme biologic	—	—

Phase I/II Trial rHuKFG for the Treatment of Steroid Refractory Gastrointestinal Acute GVHD

Summary

Timeline

Drugs

Indications